As World Confronts Omicron Variant, Top 8 Pfizer & Moderna Investors Make $10 Billion in a Week

This is a rush transcript. Copy may not be in its final form. AMY GOODMAN: This is Democracy Now!, Democracynow.org, the War and Peace Report. I’m Amy Goodman in New York, joined by Democracy Now! co-host Juan González in New Brunswick, New Jersey. Hi, Juan. JUAN GONZÁLEZ: Hi, Amy. Welcome to all of our listeners …
Continue reading As World Confronts Omicron Variant, Top 8 Pfizer & Moderna Investors Make $10 Billion in a Week

Public Citizen Blasts Pfizer for Putting Corporate Profit Over Increasing Access to COVID Vaccines

This is a rush transcript. Copy may not be in its final form. AMY GOODMAN: This is democracynow.org. I’m Amy Goodman. We look now at how one of the leading COVID-19 vaccine makers appears to have restricted — appears to have restricted access to those very vaccines. The People’s Vaccine Alliance says just 14% of …
Continue reading Public Citizen Blasts Pfizer for Putting Corporate Profit Over Increasing Access to COVID Vaccines

Doctors Without Borders: U.S. Should Force Pfizer to Share COVID Vaccine Technology with Africa

This is a rush transcript. Copy may not be in its final form. AMY GOODMAN: This is Democracy Now!, democracynow.org. I’m Amy Goodman. The Food and Drug Administration has fully authorized the Pfizer-BioNTech COVID-19 vaccine for U.S. residents aged 16 and over, making it the first COVID vaccine to be fully approved by the FDA. …
Continue reading Doctors Without Borders: U.S. Should Force Pfizer to Share COVID Vaccine Technology with Africa

As Delta Variant Drives COVID-19 Uptick, Pfizer Pushes 3rd Shot in US Despite Global Vaccination Lag

After months of decline in COVID-19 cases in the United States due in part to widely available vaccines, the number of new cases per day is on the rise again. Pfizer representatives met with U.S. regulators and vaccine experts to seek emergency use authorization for a second booster dose of its vaccine, as health experts …
Continue reading As Delta Variant Drives COVID-19 Uptick, Pfizer Pushes 3rd Shot in US Despite Global Vaccination Lag

UK to face short-term delay in delivery of the Pfizer vaccine

The UK is set to face short-term delays in delivery of the Pfizer coronavirus (Covid-19) vaccine as the pharmaceutical company upgrades its production capacity. Delays Pfizer is upscaling production at its plant in Puurs, Belgium. This is in an to produce more doses than originally planned for 2021 – temporarily reducing deliveries to all European …
Continue reading UK to face short-term delay in delivery of the Pfizer vaccine

As U.S. Faces Out-of-Control Pandemic, Pfizer Raises Hope for Vaccine, But Many Questions Remain

This is a rush transcript. Copy may not be in its final form. AMY GOODMAN: As the number of coronavirus cases worldwide tops more than 51 million, the U.S. pharmaceutical company Pfizer announced Monday a Phase 3, late-stage study found their potential COVID-19 vaccine shows more than 90% effectiveness. This is Pfizer CEO Albert Bourla …
Continue reading As U.S. Faces Out-of-Control Pandemic, Pfizer Raises Hope for Vaccine, But Many Questions Remain

As U.S. Faces Out-of-Control Pandemic, Pfizer Raises Hope for Vaccine, But Many Questions Remain

Pharmaceutical giant Pfizer has announced that a Phase 3, late-stage study found their potential COVID-19 vaccine showed more than 90% effectiveness. The two-dose vaccine still faces several challenges, including how to store and transport it, since it must be refrigerated at subzero temperatures. Pulitzer Prize-winning science journalist Laurie Garrett says the news is hopeful, but …
Continue reading As U.S. Faces Out-of-Control Pandemic, Pfizer Raises Hope for Vaccine, But Many Questions Remain